The Department of Health and Human Services is offering the T1DAPC-DCC grant to establish the Type 1 Diabetes in Acute Pancreatitis Consortium Data Coordinating Center. This grant aims to conduct a prospective longitudinal observational study on the occurrence of type 1 diabetes after acute pancreatitis episodes, focusing on understanding its clinical evolution, etiology, and pathophysiology. The grant will also support research on immune and genetic risk factors and biomarkers for predicting type 1 diabetes development in a diverse population. The Data Coordinating Center will provide project coordination, quality control, and biostatistical support for this important research endeavor. Deadline: Mar 13, 2020.
Opportunity ID: 322944
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-19-023 |
| Funding Opportunity Title: | Type 1 Diabetes in Acute Pancreatitis Consortium – Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 09, 2019 |
| Last Updated Date: | Dec 09, 2019 |
| Original Closing Date for Applications: | Mar 13, 2020 |
| Current Closing Date for Applications: | Mar 13, 2020 |
| Archive Date: | Apr 18, 2020 |
| Estimated Total Program Funding: | $2,300,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities City or township governments For profit organizations other than small businesses State governments County governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits U01 applications for the establishment of a clinical consortium, the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC), composed of one Data Coordinating Center (DCC) and up to 10 Clinical Centers (CC), to conduct studies on Type 1 diabetes mellitus (T1D) that occurs after or as a consequence of one or more episodes of acute pancreatitis. Applications for the Clinical Centers (CC) are submitted in response to a separate FOA: RFA-DK-19-022: Type 1 Diabetes in Acute Pancreatitis Consortium Clinical Centers (T1DAPC-CC) (U01). The applicant for the Data Coordinating Center (DCC) must have experience serving as the DCC for studies on complex, clinical conditions, like the occurrence of diabetes mellitus (DM) after or as a consequence of one or more episodes of acute pancreatitis. The Consortium will form multi-disciplinary teams composed of members from the CCs and the DCC to undertake a prospective longitudinal observational study of the occurrence of diabetes that occurs during an acute pancreatitis episode or subsequently, with an emphasis on type 1 diabetes (T1D). The study will be designed to gain insight into the incidence, clinical evolution, etiology, type and pathophysiology of the T1D and other forms of diabetes after acute pancreatitis.. The Consortia will also undertake studies on the identification of immune and genetic risk factors and biomarkers which predict the development of T1D in a racially, ethnically, and geographically diverse population of subjects who have recovered from one or more episodes of acute pancreatitis due to various identifiable etiologies. The DCC will provide overall project coordination, administration, quality control, data management and biostatistical support. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-023.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00257062 | Feb 13, 2020 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259553 | Feb 13, 2020 | Mar 13, 2020 | View |
Package 1
Mandatory forms
322944 RR_SF424_2_0-2.0.pdf
322944 PHS398_CoverPageSupplement_4_0-4.0.pdf
322944 RR_OtherProjectInfo_1_4-1.4.pdf
322944 PerformanceSite_2_0-2.0.pdf
322944 RR_KeyPersonExpanded_2_0-2.0.pdf
322944 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
322944 RR_Budget_1_4-1.4.pdf
322944 RR_SubawardBudget30_1_4-1.4.pdf
322944 PHS398_ModularBudget_1_2-1.2.pdf
322944 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
322944 RR_SF424_2_0-2.0.pdf
322944 PHS398_CoverPageSupplement_5_0-5.0.pdf
322944 RR_OtherProjectInfo_1_4-1.4.pdf
322944 PerformanceSite_2_0-2.0.pdf
322944 RR_KeyPersonExpanded_2_0-2.0.pdf
322944 PHS398_ResearchPlan_4_0-4.0.pdf
322944 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
322944 RR_Budget_1_4-1.4.pdf
322944 RR_SubawardBudget30_1_4-1.4.pdf
322944 PHS398_ModularBudget_1_2-1.2.pdf
322944 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
